Cargando…

O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokose, Takahiro, Kabe, Yasuaki, Matsuda, Atsushi, Kitago, Minoru, Matsuda, Sachiko, Hirai, Miwa, Nakagawa, Tomomi, Masugi, Yohei, Hishiki, Takako, Nakamura, Yuki, Shinoda, Masahiro, Yagi, Hiroshi, Abe, Yuta, Oshima, Go, Hori, Shutaro, Nakano, Yutaka, Honda, Kazufumi, Kashiro, Ayumi, Morizane, Chigusa, Nara, Satoshi, Kikuchi, Shojiro, Shibahara, Takahiko, Itonaga, Makoto, Ono, Masayuki, Minegishi, Naoko, Koshiba, Seizo, Yamamoto, Masayuki, Kuno, Atsushi, Handa, Hiroshi, Sakamoto, Michiie, Suematsu, Makoto, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563872/
https://www.ncbi.nlm.nih.gov/pubmed/32878320
http://dx.doi.org/10.3390/cancers12092469
_version_ 1783595585466531840
author Yokose, Takahiro
Kabe, Yasuaki
Matsuda, Atsushi
Kitago, Minoru
Matsuda, Sachiko
Hirai, Miwa
Nakagawa, Tomomi
Masugi, Yohei
Hishiki, Takako
Nakamura, Yuki
Shinoda, Masahiro
Yagi, Hiroshi
Abe, Yuta
Oshima, Go
Hori, Shutaro
Nakano, Yutaka
Honda, Kazufumi
Kashiro, Ayumi
Morizane, Chigusa
Nara, Satoshi
Kikuchi, Shojiro
Shibahara, Takahiko
Itonaga, Makoto
Ono, Masayuki
Minegishi, Naoko
Koshiba, Seizo
Yamamoto, Masayuki
Kuno, Atsushi
Handa, Hiroshi
Sakamoto, Michiie
Suematsu, Makoto
Kitagawa, Yuko
author_facet Yokose, Takahiro
Kabe, Yasuaki
Matsuda, Atsushi
Kitago, Minoru
Matsuda, Sachiko
Hirai, Miwa
Nakagawa, Tomomi
Masugi, Yohei
Hishiki, Takako
Nakamura, Yuki
Shinoda, Masahiro
Yagi, Hiroshi
Abe, Yuta
Oshima, Go
Hori, Shutaro
Nakano, Yutaka
Honda, Kazufumi
Kashiro, Ayumi
Morizane, Chigusa
Nara, Satoshi
Kikuchi, Shojiro
Shibahara, Takahiko
Itonaga, Makoto
Ono, Masayuki
Minegishi, Naoko
Koshiba, Seizo
Yamamoto, Masayuki
Kuno, Atsushi
Handa, Hiroshi
Sakamoto, Michiie
Suematsu, Makoto
Kitagawa, Yuko
author_sort Yokose, Takahiro
collection PubMed
description SIMPLE SUMMARY: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the serum of PC patients. These specific EVs with O-glycans can act as potential biomarkers in a liquid biopsy for PC patients screening. ABSTRACT: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum (two cohorts including 117 PC patients and 98 normal controls) using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the culture of PC cell lines or in the serum of PC patients including carbohydrate antigen 19-9 negative patients with high area under curve values. The elevated numbers of EVs in PC serum returned to normal levels after pancreatectomy. Histological examination confirmed that the tumors stained with ABA/ACA. These specific EVs with O-glycans recognized by ABA/ACA are elevated in PC sera and can act as potential biomarkers in a liquid biopsy for PC patients screening.
format Online
Article
Text
id pubmed-7563872
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75638722020-10-27 O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer Yokose, Takahiro Kabe, Yasuaki Matsuda, Atsushi Kitago, Minoru Matsuda, Sachiko Hirai, Miwa Nakagawa, Tomomi Masugi, Yohei Hishiki, Takako Nakamura, Yuki Shinoda, Masahiro Yagi, Hiroshi Abe, Yuta Oshima, Go Hori, Shutaro Nakano, Yutaka Honda, Kazufumi Kashiro, Ayumi Morizane, Chigusa Nara, Satoshi Kikuchi, Shojiro Shibahara, Takahiko Itonaga, Makoto Ono, Masayuki Minegishi, Naoko Koshiba, Seizo Yamamoto, Masayuki Kuno, Atsushi Handa, Hiroshi Sakamoto, Michiie Suematsu, Makoto Kitagawa, Yuko Cancers (Basel) Article SIMPLE SUMMARY: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the serum of PC patients. These specific EVs with O-glycans can act as potential biomarkers in a liquid biopsy for PC patients screening. ABSTRACT: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum (two cohorts including 117 PC patients and 98 normal controls) using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the culture of PC cell lines or in the serum of PC patients including carbohydrate antigen 19-9 negative patients with high area under curve values. The elevated numbers of EVs in PC serum returned to normal levels after pancreatectomy. Histological examination confirmed that the tumors stained with ABA/ACA. These specific EVs with O-glycans recognized by ABA/ACA are elevated in PC sera and can act as potential biomarkers in a liquid biopsy for PC patients screening. MDPI 2020-08-31 /pmc/articles/PMC7563872/ /pubmed/32878320 http://dx.doi.org/10.3390/cancers12092469 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yokose, Takahiro
Kabe, Yasuaki
Matsuda, Atsushi
Kitago, Minoru
Matsuda, Sachiko
Hirai, Miwa
Nakagawa, Tomomi
Masugi, Yohei
Hishiki, Takako
Nakamura, Yuki
Shinoda, Masahiro
Yagi, Hiroshi
Abe, Yuta
Oshima, Go
Hori, Shutaro
Nakano, Yutaka
Honda, Kazufumi
Kashiro, Ayumi
Morizane, Chigusa
Nara, Satoshi
Kikuchi, Shojiro
Shibahara, Takahiko
Itonaga, Makoto
Ono, Masayuki
Minegishi, Naoko
Koshiba, Seizo
Yamamoto, Masayuki
Kuno, Atsushi
Handa, Hiroshi
Sakamoto, Michiie
Suematsu, Makoto
Kitagawa, Yuko
O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
title O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
title_full O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
title_fullStr O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
title_full_unstemmed O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
title_short O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
title_sort o-glycan-altered extracellular vesicles: a specific serum marker elevated in pancreatic cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563872/
https://www.ncbi.nlm.nih.gov/pubmed/32878320
http://dx.doi.org/10.3390/cancers12092469
work_keys_str_mv AT yokosetakahiro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT kabeyasuaki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT matsudaatsushi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT kitagominoru oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT matsudasachiko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT hiraimiwa oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT nakagawatomomi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT masugiyohei oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT hishikitakako oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT nakamurayuki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT shinodamasahiro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT yagihiroshi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT abeyuta oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT oshimago oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT horishutaro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT nakanoyutaka oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT hondakazufumi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT kashiroayumi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT morizanechigusa oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT narasatoshi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT kikuchishojiro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT shibaharatakahiko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT itonagamakoto oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT onomasayuki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT minegishinaoko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT koshibaseizo oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT yamamotomasayuki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT kunoatsushi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT handahiroshi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT sakamotomichiie oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT suematsumakoto oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer
AT kitagawayuko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer